Presentation TCT 2019 TCT 16: Longitudinal Distribution of Lipid Rich Plaque in Nonculprit Lesions: A Lipid Rich Plaque (LRP) Study Sub-analysis Presenter: Evan Shlofmitz September 25, 2019 REGISTER for free or LOG IN to view this content Coronary Presentation TCT 2019 Plaque Modification Up Next Presentation TCT 2019 TCT 13: Alirocumab improve coronary plaque vulnerability: first randomized control trial to assess the effect of alirocumab for plaque vulnerabilityusing optical coherence tomography. Presenter: yoichiro sugizaki September 25, 2019 More slides + Presentation TCT 2019 TCT 14: Assessment of the Sources of Near-infrared Auto-fluorescence in High-risk Coronary Artery Plaques: a Histopathologic Correlative Study Presenter: Mie Kunio September 25, 2019 Presentation TCT 2019 TCT 15: Prognostic Impact of Healed Coronary Plaque in Non-culprit Segments Assessed by Optical Coherence Tomography Presenter: Eisuke Usui September 25, 2019 We Recommend
Presentation TCT 2019 TCT 13: Alirocumab improve coronary plaque vulnerability: first randomized control trial to assess the effect of alirocumab for plaque vulnerabilityusing optical coherence tomography. Presenter: yoichiro sugizaki September 25, 2019
Presentation TCT 2019 TCT 14: Assessment of the Sources of Near-infrared Auto-fluorescence in High-risk Coronary Artery Plaques: a Histopathologic Correlative Study Presenter: Mie Kunio September 25, 2019
Presentation TCT 2019 TCT 15: Prognostic Impact of Healed Coronary Plaque in Non-culprit Segments Assessed by Optical Coherence Tomography Presenter: Eisuke Usui September 25, 2019